PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-8.49%
Negative net income growth while CRWD stands at 30.83%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
8.84%
D&A growth well above CRWD's 11.94%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
103.07%
Well above CRWD's 107.51% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
11.46%
Less SBC growth vs. CRWD's 40.33%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
-275.14%
Both reduce yoy usage, with CRWD at -68.12%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-152.86%
Both yoy AR lines negative, with CRWD at -277.09%. Martin Whitman would suspect an overall sector lean approach or softer demand.
150.71%
Some inventory rise while CRWD is negative at -100.00%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
149.89%
AP growth well above CRWD's 250.97%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
-22.65%
Negative yoy usage while CRWD is 36.89%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
15.66%
Well above CRWD's 6.57%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-40.99%
Both yoy CFO lines are negative, with CRWD at -26.47%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-0.95%
Both yoy lines negative, with CRWD at -15.24%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
29.52%
Less M&A spending yoy vs. CRWD's 99.90%, reducing near-term risk. David Dodd would confirm the firm is not missing out on a strategic deal that competitor might exploit.
75.70%
Some yoy expansion while CRWD is negative at -358.37%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
-43.78%
We reduce yoy sales while CRWD is 9.13%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
78.66%
We have some outflow growth while CRWD is negative at -9.13%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
64.28%
Investing outflow well above CRWD's 89.30%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
100.00%
Debt repayment growth of 100.00% while CRWD is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
-52.45%
Negative yoy issuance while CRWD is 784.12%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
3.27%
Buyback growth of 3.27% while CRWD is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.